STIM1 GoF Mutants: Genotype–Phenotype Relationships Across the Stormorken/TAM/YPS Spectrum
Cells · 2026
DOI: 10.3390/cells15100926 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Lara Atzgerstorfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biophysics, JKU Life Science Center, Johannes Kepler University Linz, 4040 Linz, Austria. Hauptthemen laut MEDLINE: Stromal Interaction Molecule 1, Miosis, Blood Platelet Disorders, Ichthyosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Funding of the Austrian Science Fund.
Abstract (Originalsprache)
Store-operated Calcium (Ca2+) entry (SOCE), mediated by stromal interaction molecule 1 (STIM1) and Orai1, is a central pathway controlling intracellular Ca2+ homeostasis. Gain-of-function (GoF) mutations in STIM1 cause a spectrum of clinically overlapping disorders historically classified as Stormorken Syndrome (STK), tubular aggregate myopathy (TAM), and York Platelet Syndrome (YPS). However, increasing evidence indicates that these entities could represent a shared disease spectrum rather than distinct conditions. At the molecular level, STIM1 activation is governed by a series of autoinhibitory checkpoints that maintain the protein in a tightly controlled resting state. GoF mutations disrupt these regulatory constraints, leading to dysregulated SOCE activity that is frequently, but not uniformly, associated with constitutive channel activation depending on the specific mutation and cellular context. While many disease-associated variants localize to the EF hand, a highly conserved helix–loop–helix Ca2+ binding motif, and the CC1 (coiled-coil 1) domain involved in molecular regulation of STIM1 activation, an increasing number of mutations in the C-terminal region further expands the mechanistic and clinical spectrum. In this review, we summarize current concepts of molecular STIM1 activation and discuss how distinct mutations perturb specific regulatory elements of the protein. By systematically integrating published case reports into a comprehensive overview, including a mutation–phenotype correlation table, we highlight the remarkable variability in and incomplete penetrance of clinical manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biophysics, JKU Life Science Center, Johannes Kepler University Linz, 4040 Linz, Austria.
ORCID-Profile: Magdalena Prantl, Marc Fahrner
Förderung
- Open Access Funding of the Austrian Science Fund
Zitieren
APA
Atzgerstorfer, L., Prantl, M., Waldhauser, A., Derler, I., & Fahrner, M. (2026). STIM1 GoF Mutants: Genotype–Phenotype Relationships Across the Stormorken/TAM/YPS Spectrum. Cells. https://doi.org/10.3390/cells15100926
Vancouver
Atzgerstorfer L, Prantl M, Waldhauser A, Derler I, Fahrner M. STIM1 GoF Mutants: Genotype–Phenotype Relationships Across the Stormorken/TAM/YPS Spectrum. Cells. 2026. doi:10.3390/cells15100926
BibTeX
@article{Atzgerstorfer2026,
author = {Atzgerstorfer, Lara and Prantl, Magdalena and Waldhauser, Andrea and Derler, Isabella and Fahrner, Marc},
title = {STIM1 GoF Mutants: Genotype–Phenotype Relationships Across the Stormorken/TAM/YPS Spectrum},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15100926}
}
EUVIMED